Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
AbstractBone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggression. After reviewing the different theories proposed to provide mechanism for metastatic progression, we report on the gene expression profile of bone-seeking cancer cells. We also discuss the cross-talk between the bone microenvironment and invading cells, which impacts on the tumour actions on surrounding bone tissue. Lastly, we detail therapies for bone metastases. Due to poor prognosis for patients, the strategies mainly aim at reducing the impact of skeletal-related events on patients’ quality of life. However, recent advances have led to a better understanding of molecular mechanisms underlying bone metastases progression, and therefore of novel therapeutic targets. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Schmid-Alliana, A.; Schmid-Antomarchi, H.; Al-Sahlanee, R.; Lagadec, P.; Scimeca, J.-C.; Verron, E. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets. Int. J. Mol. Sci. 2018, 19, 148.
Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca J-C, Verron E. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets. International Journal of Molecular Sciences. 2018; 19(1):148.Chicago/Turabian Style
Schmid-Alliana, Annie; Schmid-Antomarchi, Heidy; Al-Sahlanee, Rasha; Lagadec, Patricia; Scimeca, Jean-Claude; Verron, Elise. 2018. "Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets." Int. J. Mol. Sci. 19, no. 1: 148.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.